Orchard Capital Management, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 196 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
Orchard Capital Management, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$6,501,000
-6.3%
75,4960.0%2.43%
+12.2%
Q2 2022$6,939,000
-16.2%
75,496
+2.6%
2.17%
-7.9%
Q1 2022$8,279,000
-21.9%
73,596
+7.3%
2.35%
-24.3%
Q4 2021$10,595,000
+13.0%
68,596
+1.9%
3.11%
+10.1%
Q3 2021$9,376,000
+6.2%
67,2960.0%2.82%
+10.7%
Q2 2021$8,829,000
-11.2%
67,296
+3.2%
2.55%
-18.4%
Q1 2021$9,937,000
+69.6%
65,180
+10.6%
3.13%
+25.1%
Q4 2020$5,860,00058,9212.50%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders